How many institutions held AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in Q3 2021?

44 institutional investors reported AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value for Q3 2021. Use the holders table for investor-level position and value details.

Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

Q: What does CUSIP 03843E104 represent in this 13F holders report?

CUSIP 03843E104 is the security identifier for AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 03843E104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 120,192,308
Total 13F shares: 14,777,244
Share change: -846,612
Total reported value: $64,430,510
Put/Call ratio: 106%
Price per share: $4.36
Number of holders: 44
Value change: -$3,394,828
Number of buys: 15
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP 03843E104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bratton Capital Management, L.P.	13F	Company	8.2%	9,810,958	$38,950,000	—	30 Jun 2021	13F
VANGUARD GROUP INC	13F	Company	0.87%	1,046,078	$4,153,000	—	30 Jun 2021	13F
MORGAN STANLEY	13F	Company	0.46%	553,626	$2,198,000	—	30 Jun 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.36%	437,854	$1,738,000	—	30 Jun 2021	13F
Bracebridge Capital, LLC	13F	Company	0.36%	428,571	$1,701,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	0.29%	351,014	$1,394,000	—	30 Jun 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.2%	245,448	$974,000	—	30 Jun 2021	13F
Latash Investments, LLC	13F	Company	0.2%	243,134	$965,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	219,642	$871,000	—	30 Jun 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.18%	217,091	$862,000	—	30 Jun 2021	13F
Alberta Investment Management Corp	13F	Company	0.12%	150,000	$596,000	—	30 Jun 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.11%	127,000	$504,000	—	30 Jun 2021	13F
HighTower Advisors, LLC	13F	Company	0.11%	126,805	$504,000	—	30 Jun 2021	13F
Brandywine Global Investment Management, LLC	13F	Company	0.1%	125,416	$498,000	—	30 Jun 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	125,293	$497,000	—	30 Jun 2021	13F
Bank of New York Mellon Corp	13F	Company	0.1%	115,723	$459,000	—	30 Jun 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.09%	104,934	$417,000	—	30 Jun 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	100,310	$398,000	—	30 Jun 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.08%	97,801	$388,000	—	30 Jun 2021	13F
Ergoteles LLC	13F	Company	0.08%	90,900	$361,000	—	30 Jun 2021	13F
PDT Partners, LLC	13F	Company	0.07%	81,765	$325,000	—	30 Jun 2021	13F
Tibra Equities Europe Ltd	13F	Company	0.06%	78,100	$310,000	—	30 Jun 2021	13F
IndexIQ Advisors LLC	13F	Company	0.06%	77,801	$309,000	—	30 Jun 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	74,757	$297,000	—	30 Jun 2021	13F
STATE STREET CORP	13F	Company	0.06%	69,877	$277,000	—	30 Jun 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	68,030	$270,000	—	30 Jun 2021	13F
HRT FINANCIAL LP	13F	Company	0.04%	49,907	$198,000	—	30 Jun 2021	13F
NORTHERN TRUST CORP	13F	Company	0.04%	45,454	$181,000	—	30 Jun 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	36,400	$145,000	—	30 Jun 2021	13F
BARCLAYS PLC	13F	Company	0.03%	31,382	$125,000	—	30 Jun 2021	13F
Jump Financial, LLC	13F	Company	0.03%	30,630	$122,000	—	30 Jun 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	28,728	$114,000	—	30 Jun 2021	13F
Cresset Asset Management, LLC	13F	Company	0.02%	25,000	$99,000	—	30 Jun 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0.02%	21,020	$87,000	—	30 Jun 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	21,144	$84,000	—	30 Jun 2021	13F
Squarepoint Ops LLC	13F	Company	0.02%	19,824	$79,000	—	30 Jun 2021	13F
Virtu Financial LLC	13F	Company	0.02%	18,521	$74,000	—	30 Jun 2021	13F
Financial Advocates Investment Management	13F	Company	0.01%	17,000	$67,000	—	30 Jun 2021	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.01%	15,644	$62,000	—	30 Jun 2021	13F
UBS Group AG	13F	Company	0.01%	14,060	$56,000	—	30 Jun 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	13,992	$56,000	—	30 Jun 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	13,399	$53,000	—	30 Jun 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	13,099	$52,000	—	30 Jun 2021	13F
LMR Partners LLP	13F	Company	0.01%	12,090	$48,000	—	30 Jun 2021	13F
WEDBUSH SECURITIES INC	13F	Company	0.01%	10,500	$42,000	—	30 Jun 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	7,274	$29,000	—	30 Jun 2021	13F
James S. Scibetta	3/4/5	Director	— mixed-class rows	51,635 mixed-class rows	$25,624	—	15 Jun 2021	3/4/5
Rockefeller Capital Management L.P.	13F	Company	0%	3,166	$12,000	—	30 Jun 2021	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0%	2,600	$10,000	—	30 Jun 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	2,000	$8,000	—	30 Jun 2021	13F

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q3 2021

As of 30 Sep 2021, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,777,244 shares. The largest 10 holders included Bratton Capital Management, L.P., VANGUARD GROUP INC, Bracebridge Capital, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, MORGAN STANLEY, Latash Investments, LLC, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

-12

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.